SCHEMBL387177

SCHEMBL387177

CCC(O)(C(=O)O)C(O)(CC)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
TSHR P16473 3/20 0.44
ACLY P53396 2/20 0.40
FFAR3 O14843 2/20 0.39
MEN1 O00255 2/20 0.37
CYP1A2 P05177 2/20 0.37
KMT2A Q03164 2/20 0.37
THRB P10828 1/20 0.37
HMGCR P04035 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
ADRA1A P35348 1/20 0.36
TET2 Q6N021 2/20 0.36
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
HIF1A Q16665 1/20 0.35
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1197211 1.00 ALDH1A1 (0.44) ALDH1A1TSHRACLYFFAR3MEN1
SCHEMBL1196173 1.00 ALDH1A1 (0.44) ALDH1A1TSHRACLYFFAR3MEN1
SCHEMBL22440902 1.00 ALDH1A1 (0.44) ALDH1A1TSHRACLYFFAR3MEN1
Boric Acid SCHEMBL30679497 0.91 ALDH1A1 (0.38) ALDH1A1TSHRACLYFFAR3MEN1
Boric Acid SCHEMBL30679498 0.91 ALDH1A1 (0.38) ALDH1A1TSHRACLYFFAR3MEN1
Isopropyl Alcohol SCHEMBL19951528 0.89 ALDH1A1 (0.36) ALDH1A1TSHRACLYFFAR3MEN1
Isopropyl Alcohol SCHEMBL19951527 0.87 ALDH1A1 (0.35) ALDH1A1TSHRACLYFFAR3MEN1
SCHEMBL30791101 0.87 ACLY (0.54) ALDH1A1TSHRACLYFFAR3MEN1
SCHEMBL11418482 0.85 TSHR (0.45) ALDH1A1TSHRACLYFFAR3MEN1
SCHEMBL28448094 0.85 ALDH1A1 (0.38) ALDH1A1TSHRACLYFFAR3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 442 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3934622-B1 DELAYED RELEASE METHYLPHENIDATE COMPOSITIONS AMNEAL COMPLEX PRODUCTS RES LLC (US) 2026-05-06 EP claimed
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
US-11739050-B2 Method for purification of terpenoid amino alcohol derivatives SCI PHARMTECH INC. (TW) 2023-08-29 US claimed
EP-3685828-B1 OPHTHALMIC PHARMACEUTICAL COMPOSITION, OPHTHALMIC KIT, AND PHARMACEUTICAL APPLICATION THEREOF SHENYANG XINGQI PHARMACEUTICAL CO LTD (CN) 2023-04-19 EP claimed
US-20230103071-A1 METHOD FOR PURIFICATION OF TERPENOID AMINO ALCOHOL DERIVATIVES SCI PHARMTECH INC. (TW) 2023-03-30 US claimed
EP-4144717-A1 METHOD FOR PURIFICATION OF TERPENOID AMINO ALCOHOL DERIVATIVES SCI Pharmtech Inc (TW) 2023-03-08 EP claimed
EP-1215305-A1 Method for preparing an electroplating bath and related copper plating process INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM VZW (BE) 2002-06-19 EP claimed
EP-1103633-A1 Method for copper plating deposition INTERUNIVERSITAIR MICROELEKTRONICA CENTRUM VZW (BE) 2001-05-30 EP claimed
EP-0772646-B1 FLUOROELASTOMER MOULDING PROCESS DU PONT (US) 2000-03-01 EP claimed
EP-0772646-A4 FLUOROELASTOMER MOULDING PROCESS DU PONT (US) 1997-12-10 EP claimed
EP-0772646-A1 FLUOROELASTOMER MOULDING PROCESS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-05-14 EP claimed
WO-1996001870-A1 FLUOROELASTOMER MOULDING PROCESS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-01-25 WO claimed
EP-0693704-A1 Semi-organic crystals for nonlinear optical devices ROCKWELL INTERNATIONAL CORPORATION (US) 1996-01-24 EP claimed
EP-0691371-A1 Fluoroelastomer compositions DU PONT DE NEMOURS INTERNATIONAL S.A. (CH) 1996-01-10 EP claimed
EP-0255379-B1 Optically active alcohols, process for producing the same, and process for resolving the same NISSAN CHEMICAL IND LTD (JP) 1995-11-15 EP claimed
US-5208352-A Process for preparing the R- and S-isomers of 2-hydroxy-methyl-2-octadecyloxymethyl-tetrahydrofuran and their use in preparing stereoisomers of pharmacologically active compounds SANDOZ LTD. (CH) 1993-05-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739050-B2 Method for purification of terpenoid amino alcohol derivatives ADH1A, MSMO1, MED1 ALDH1A1 803/4885TSHR 3612/4885ACLY 3858/4885
US-20230103071-A1 METHOD FOR PURIFICATION OF TERPENOID AMINO ALCOHOL DERIVATIVES ADH1A, MSMO1, MED1 ALDH1A1 803/4885TSHR 3612/4885ACLY 3858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.